Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Biopharma Cred. (BPCR) Share Price

Price $0.926 on 06-02-2026 at 19:40:05
Change $0.006 0.65%
Buy $0.928
Sell $0.918
Last Trade: Buy 2,000.00 at $0.926
Day's Volume: 476,388
Last Close: $0.926
Open: $0.92
ISIN: GB00BDGKMY29
Day's Range $0.92 - $0.928
52wk Range: $0.80 - $0.94
Market Capitalisation: $1.05b
VWAP: $0.925077
Shares in Issue: 1.13b

Biopharma Cred. (BPCR) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 2,000 $0.926 Automatic Execution
16:35:10 - 06-Feb-26
Buy* 26,933 $0.926 Suspected BUY Trade
16:35:10 - 06-Feb-26
Unknown* 2,938 $0.922261 Ordinary
Currency Conversion
16:24:37 - 06-Feb-26
Buy* 2,438 $0.926 Automatic Execution
16:21:19 - 06-Feb-26
Buy* 251 $0.9244 Ordinary
16:12:05 - 06-Feb-26
Unknown* 887 $0.924321 Ordinary
Currency Conversion
16:09:57 - 06-Feb-26
Unknown* 145,902 $0.924063 Ordinary
Currency Conversion
16:08:11 - 06-Feb-26
Sell* 18 $0.926 Automatic Execution
16:04:14 - 06-Feb-26
Sell* 6 $0.926 Automatic Execution
16:04:14 - 06-Feb-26
Sell* 4 $0.924 Automatic Execution
16:04:12 - 06-Feb-26
See more Biopharma Cred. trades

Biopharma Cred. (BPCR) Share Price History

Time period:
to
Date Open High Low Close Volume
6th Feb 2026 (Fri) 0.92 0.928 0.92 0.926 476,388
5th Feb 2026 (Thu) 0.926 0.928 0.916 0.92 1,289,661
4th Feb 2026 (Wed) 0.926 0.93 0.926 0.93 338,034
3rd Feb 2026 (Tue) 0.922 0.934 0.922 0.93 955,723
2nd Feb 2026 (Mon) 0.92 0.93 0.92 0.93 971,828
30th Jan 2026 (Fri) 0.922 0.932 0.922 0.924 513,208
29th Jan 2026 (Thu) 0.928 0.928 0.922 0.926 1,058,411
28th Jan 2026 (Wed) 0.916 0.93 0.914 0.916 1,857,060
27th Jan 2026 (Tue) 0.908 0.928 0.908 0.91 710,686
26th Jan 2026 (Mon) 0.908 0.914 0.908 0.91 1,738,177
23rd Jan 2026 (Fri) 0.906 0.916 0.906 0.906 1,641,315
22nd Jan 2026 (Thu) 0.904 0.908 0.904 0.906 1,237,728
21st Jan 2026 (Wed) 0.90 0.908 0.90 0.904 1,803,119
20th Jan 2026 (Tue) 0.90 0.904 0.90 0.90 920,208
19th Jan 2026 (Mon) 0.91 0.91 0.90 0.902 1,070,918
16th Jan 2026 (Fri) 0.91 0.922 0.91 0.912 1,274,902
15th Jan 2026 (Thu) 0.904 0.92 0.904 0.914 1,389,282
14th Jan 2026 (Wed) 0.904 0.908 0.902 0.902 2,445,482
13th Jan 2026 (Tue) 0.91 0.914 0.908 0.908 1,958,699
12th Jan 2026 (Mon) 0.91 0.91 0.90 0.908 765,421
9th Jan 2026 (Fri) 0.904 0.91 0.902 0.908 570,269
8th Jan 2026 (Thu) 0.908 0.908 0.896 0.906 772,512
7th Jan 2026 (Wed) 0.908 0.918 0.908 0.908 667,421
See more Biopharma Cred. price history

Biopharma Cred. (BPCR) Regulatory News

Date Source Headline
3rd Feb 2026 7:00 am RNS Notice of Full Year Results
23rd Jan 2026 4:00 pm RNS Net Asset Value(s) and Monthly Factsheet
30th Dec 2025 1:32 pm RNS STATEMENT RE COLLEGIUM PREPAYMENT
30th Dec 2025 1:32 pm RNS STATEMENT RE COLLEGIUM PREPAYMENT
19th Dec 2025 4:00 pm RNS Net Asset Value(s) and Monthly Factsheet
21st Nov 2025 4:00 pm RNS Net Asset Value(s) and Monthly Factsheet
4th Nov 2025 3:29 pm RNS Director/PDMR Shareholding
24th Oct 2025 4:00 pm RNS Net Asset Value(s) and Monthly Factsheet
21st Oct 2025 7:00 am RNS UPDATES ON INVESTMENT PORTFOLIO
7th Oct 2025 7:00 am RNS NEW INVESTMENT OF US$30 MILLION
See more Biopharma Cred. regulatory news

Biopharma Cred. (BPCR) Share News

IN BRIEF: BioPharma Credit receives funds from loan prepayment

30th Dec 2025 19:48

BioPharma Credit PLC - London-based closed-ended investment company focused on life sciences industry - Notes Collegium Pharmaceutical Inc's repayment in full of a USD645.8 million senior secured term loan, in which BioPharma Credit had invested USD290.4 million in July 2024. It receives prepayment proceeds of USD261.4 million of principal with USD2.6 million of prepayment fees and USD5.3 million of accrued interest. BioPharma Credit says its cash balance is now around USD405 million. Read More

UK dividends calendar - next 7 days

24th Oct 2025 11:25

Read More

IN BRIEF: Biopharma Credit increases loan commitment to Valneva

7th Oct 2025 11:22

BioPharma Credit PLC - London-based closed-ended investment company focused on life sciences industry - Provides a senior secured loan to Valneva Austria GmbH, a subsidiary of Valneva SE. Initial tranche is expected to be funded in the coming weeks, with BioPharma investing USD30 million and BioPharma Credit Investments V (Master) LP investing an additional USD185 million in parallel, and BioPharma acting as collateral agent. "Further tranches of up to USD285 million for potential business development are subject to mutual agreement by the parties with loan allocations to be determined at such time," BioPharma adds. The loan to Valneva will mature in October 2030 and bear an interest of 9.00% per year. Read More

BioPharma Credit expects pipeline growth as net asset value ticks up

22nd Sep 2025 09:37

(Alliance News) - BioPharma Credit PLC on Monday said net asset value increased, while the net income for the first half of the year substantially covered its annual dividend target. Read More

UK earnings, trading statements calendar - next 7 days

15th Sep 2025 15:29

Read More

See more Biopharma Cred. news
FTSE 100 Latest
Value10,369.75
Change60.53

Login to your account

Forgot Password?

Not Registered